4//SEC Filing
Randhawa Simrat 4
Accession 0000950170-23-049695
CIK 0001690585other
Filed
Sep 24, 8:00 PM ET
Accepted
Sep 25, 4:15 PM ET
Size
5.8 KB
Accession
0000950170-23-049695
Insider Transaction Report
Form 4
Randhawa Simrat
EVP, Head of R&D
Transactions
- Purchase
Common Stock
2023-09-22$13.20/sh+2,000$26,400→ 4,000 total - Purchase
Common Stock
2023-09-21$13.20/sh+2,000$26,400→ 2,000 total
Documents
Issuer
Dianthus Therapeutics, Inc. /DE/
CIK 0001690585
Entity typeother
Related Parties
1- filerCIK 0001992260
Filing Metadata
- Form type
- 4
- Filed
- Sep 24, 8:00 PM ET
- Accepted
- Sep 25, 4:15 PM ET
- Size
- 5.8 KB